Okazaki-Hada M - Search Results

1

Potential Utility of Circulating MicroRNA-483 as a Biomarker for IGF-II-Associated Non-Islet Cell Tumor Hypoglycemia.

Okazaki-Hada M, Nagao M, Asai A, Okada-Iwabu M, Hizuka N, Eliasson L, Sugihara H, Fukuda I, Iwabu M. Okazaki-Hada M, et al. J Clin Endocrinol Metab. 2024 Dec 17:dgae879. doi: 10.1210/clinem/dgae879. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 39689018

2

A case of pheochromocytoma associated with liver abscess and intestinal pseudo-obstruction.

Okazaki-Hada M, Fukuda I, Nagaoka R, Nagao M, Igarashi T, Kobayashi S, Oba T, Yamaguchi Y, Nagamine T, Sugitani I, Sugihara H. Okazaki-Hada M, et al. Ther Adv Endocrinol Metab. 2022 Dec 10;13:20420188221139652. doi: 10.1177/20420188221139652. eCollection 2022. Ther Adv Endocrinol Metab. 2022. PMID: 36533183 Free PMC article.

3

HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency.

Ono M, Fukuda I, Nagao M, Tomiyama K, Okazaki-Hada M, Shuto Y, Kobayashi S, Yamaguchi Y, Nagamine T, Nakajima Y, Inagaki-Tanimura K, Sugihara H. Ono M, et al. Among authors: okazaki hada m. Pituitary. 2022 Aug;25(4):615-621. doi: 10.1007/s11102-022-01231-1. Epub 2022 Jun 2. Pituitary. 2022. PMID: 35653047

4

Proportion of serum thyroid hormone concentrations within the reference ranges in athyreotic patients on levothyroxine monotherapy: a retrospective study.

Ito M, Takahashi S, Okazaki-Hada M, Minakata M, Kohsaka K, Nakamura T, Kasahara T, Kudo T, Nishihara E, Fukata S, Nishikawa M, Akamiuzu T, Miyauchi A. Ito M, et al. Among authors: okazaki hada m. Thyroid Res. 2022 May 10;15(1):9. doi: 10.1186/s13044-022-00127-3. Thyroid Res. 2022. PMID: 35534833 Free PMC article.

5

Autoimmune thyroid disease and thyroid function test fluctuations in patients with resistance to thyroid hormone.

Okazaki-Hada M, Nishihara E, Hisakado M, Kudo T, Ito M, Fukata S, Nishikawa M, Akamizu T, Miyauchi A. Okazaki-Hada M, et al. Eur J Endocrinol. 2021 Dec 2;186(1):73-82. doi: 10.1530/EJE-21-0584. Eur J Endocrinol. 2021. PMID: 34727089

6

Risk Preferences, Rationality of Choices, and Willingness to Pay for Preventive Medicine in Patients with Graves' Thyrotoxicosis.

Emoto N, Okazaki-Hada M, Yamaguchi Y, Okajima F, Goto R, Sugihara H. Emoto N, et al. Among authors: okazaki hada m. Patient Prefer Adherence. 2021 Sep 7;15:1971-1979. doi: 10.2147/PPA.S323472. eCollection 2021. Patient Prefer Adherence. 2021. PMID: 34522090 Free PMC article.

7

Poorly Differentiated Thyroid Carcinoma Coexisting with Graves' Disease Involving T3 Thyrotoxicosis due to Increased D1 and D2 Activities.

Okazaki-Hada M, Maruoka A, Yamamoto M, Ito M, Hirokawa M, Nishikawa M, Akamizu T, Miyauchi A, Toyoda N. Okazaki-Hada M, et al. Thyroid. 2021 Oct;31(10):1592-1596. doi: 10.1089/thy.2021.0082. Epub 2021 Aug 20. Thyroid. 2021. PMID: 34278816

8

Different pathogenesis of glucose intolerance in two subtypes of primary aldosteronism: Aldosterone-producing adenoma and idiopathic hyperaldosteronism.

Okazaki-Hada M, Moriya A, Nagao M, Oikawa S, Fukuda I, Sugihara H. Okazaki-Hada M, et al. J Diabetes Investig. 2020 Nov;11(6):1511-1519. doi: 10.1111/jdi.13312. Epub 2020 Jun 26. J Diabetes Investig. 2020. PMID: 32470155 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters